Calling the reports completely misleading, fallacious, and ill-informed the Health Ministry said, "The government of India and the national regulator Central Drugs Standard Control Organisation (CDSCO) have followed a scientific approach and prescribed norms in approving the Covid-19 vaccines for emergency use authorization."
Ella, Chairman, and MD of Bharat Biotech, which produces Covaxin, met state Minister for Large and Medium Industries Dr. Murugesh R. Nirani, in Hyderabad on Friday, stated the official press release from the ministry of large and medium industries.
The study by 'bioRxiv', an open-access preprint repository for the biological sciences, shared on Tuesday that its study shows that administration of Covaxin booster dose will enhance the vaccine effectiveness against the Delta variant infection and give protection against the Omicron variants BA.1.1 and BA.2.
According to the Union Health Ministry, dedicated centres can be established for the same.
The development has come after the World Health Organisation approved Covaxin for emergency use listing last week.
Efficacy determined under 18-59 age group was 79.4% in symptomatic Covid-19 situation while it reduced to 67.8% among participants aged 60 and above in similar situation.
Covaxin comprises a disabled form of SARS-CoV-2 that cannot replicate but still stimulates the immune system to make antibodies against the virus
It is anticipated that even with administration of effective authorized vaccines, breakthrough cases are expected to happen, till the immunity reaches sufficient levels among the population to further decrease transmission.
VIMHANS hospital is getting the doses of Covaxin at Rs 1,310 from a corporate hospital based in Noida.
The company's co-founder and joint managing director Suchitra Ella on Wednesday tweeted that Andhra Pradesh, Assam, Delhi, Gujarat, Karnataka, Madhya Pradesh, Maharashtra, Tamil Nadu, and Telangana were supplied the vaccines through the government of India from June 8 to 14.
